fda compounding semaglutide news today The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the Compounding pharmacies to halt semaglutide

Ashley Koff, RD, is the author o f Your Best Shot: The Personalized System for Optimal Weight Health GLP-1 Shot or Not and the Founder of The Better Nutrition Program.

Its a different tool for a different situation. Medical Supervision and Dose Adjustments At its core, microdosing is not a do-it-yourself concept

Kristensen et al., 2019)

Managing Respiratory Symptoms While Taking Ozempic If a patient experiences mild respiratory symptoms whilst taking Ozempic and serious causes have been excluded through appropriate medical assessment, several management strategies may help alleviate discomfort whilst continuing treatment

Extending any step to 8 weeks instead of 4 significantly reduces GI side effects for most people

These details help clinicians decide whether to pause dose escalation, switch compounds (e.g., to tirzepatide or the Microdose Protocol), or introduce GI support strategies like dietary fiber timing or hydration adjustments